TMC435350-TiDP16-C106: A Phase I Trial to Compare the Bioavailability and Plasma Pharmacokinetics After a Single Oral Dose of TMC435350 of 2 Different Solid Formulations Relative to a Powder Blend Capsule
This study has been completed.
Study NCT00752648
Information provided by Tibotec Pharmaceuticals, Ireland
First Received on September 11, 2008.
Last Updated on April 26, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
